I agree with zipjet, which is something that does not happen around here every day :- ) Peptimmune filed its CP on 10/4/10 (#msg-55116264); 180 days from 10/4/10 is 4/1/11 (this Friday), so the FDA had a statutory requirement to respond to Peptimmune in the next two days.
Bottom line: I would not draw any inference about NVS/MNTA’s Copaxone ANDA or MYL’s Copaxone ANDA from the timing of the FDA response to Peptimmune.
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”